Personalized treatment of alcohol dependence

作者: Henry R. Kranzler , James R. McKay

DOI: 10.1007/S11920-012-0296-5

关键词:

摘要: Pharmacogenetic and adaptive treatment approaches can be used to personalize care for alcohol-dependent patients. Preliminary evidence shows that variation in the gene encoding μ-opioid receptor moderates response naltrexone when treat alcohol dependence. Studies have also shown moderating effects of serotonin transporter on serotonergic Adaptive algorithms modify based patients’ progress promise. Initial outpatient appears a particularly important selection optimal continuing interventions. In addition, stepped-care reduce cost burden while maintaining good outcomes. Finally, matching specific problems present at intake or emerge during improve Although all these require replication further refinement, future personalized dependence bright.

参考文章(66)
Personalized medicine in psychiatry: ethical challenges and opportunities Dialogues in clinical neuroscience. ,vol. 11, pp. 427- 434 ,(2009) , 10.31887/DCNS.2009.11.4/KEVERS
Henry R. Kranzler, Stephen Armeli, Howard Tennen, Jonathan Covault, Richard Feinn, Albert J. Arias, Helen Pettinati, Cheryl Oncken, A Double-blind, Randomized Trial of Sertraline for Alcohol Dependence: Moderation by Age of Onset and 5-HTTLPR Genotype Journal of Clinical Psychopharmacology. ,vol. 31, pp. 22- 30 ,(2011) , 10.1097/JCP.0B013E31820465FA
W Berrettini, X Yuan, F Tozzi, K Song, C Francks, H Chilcoat, D Waterworth, P Muglia, V Mooser, α-5/α-3 nicotinic receptor subunit alleles increase risk for heavy smoking Molecular Psychiatry. ,vol. 13, pp. 368- 373 ,(2008) , 10.1038/SJ.MP.4002154
Antonio‐Javier Chamorro, Miguel Marcos, José‐Antonio Mirón‐Canelo, Isabel Pastor, Rogelio González‐Sarmiento, Francisco‐Javier Laso, None, Association of µ-opioid receptor (OPRM1) gene polymorphism with response to naltrexone in alcohol dependence: a systematic review and meta-analysis Addiction Biology. ,vol. 17, pp. 505- 512 ,(2012) , 10.1111/J.1369-1600.2012.00442.X
Henry R. Kranzler, Joseph A. Burleson, Joseph Brown, Thomas F. Babor, Fluoxetine Treatment Seems to Reduce the Beneficial Effects of Cognitive-Behavioral Therapy in Type B Alcoholics Alcoholism: Clinical and Experimental Research. ,vol. 20, pp. 1534- 1541 ,(1996) , 10.1111/J.1530-0277.1996.TB01696.X
James R. McKay, Kevin G. Lynch, Donald S. Shepard, Helen M. Pettinati, The Effectiveness of Telephone-Based Continuing Care for Alcohol and Cocaine Dependence: 24-Month Outcomes Archives of General Psychiatry. ,vol. 62, pp. 199- 207 ,(2005) , 10.1001/ARCHPSYC.62.2.199
David LeMarquand, Robert O. Pihl, Chawki Benkelfat, Serotonin and alcohol intake, abuse, and dependence: Clinical evidence Biological Psychiatry. ,vol. 36, pp. 326- 337 ,(1994) , 10.1016/0006-3223(94)90630-0
Bankole A. Johnson, Nassima Ait-Daoud, Chamindi Seneviratne, John D. Roache, Martin A. Javors, Xin-Qun Wang, Lei Liu, J. Kim Penberthy, Carlo C. DiClemente, Ming D. Li, Pharmacogenetic Approach at the Serotonin Transporter Gene as a Method of Reducing the Severity of Alcohol Drinking American Journal of Psychiatry. ,vol. 168, pp. 265- 275 ,(2011) , 10.1176/APPI.AJP.2010.10050755
Sung-Gon Kim, Cheol-Min Kim, Sam-Wook Choi, Young-Myo Jae, Hae-Gook Lee, Bong-Ki Son, Jeong-Gee Kim, Young-Sung Choi, Han-Oh Kim, Seong-Yeon Kim, David W. Oslin, A mu opioid receptor gene polymorphism (A118G) and naltrexone treatment response in adherent Korean alcohol-dependent patients Psychopharmacology. ,vol. 201, pp. 611- 618 ,(2009) , 10.1007/S00213-008-1330-5
A W Bergen, J Kokoszka, R Peterson, J C Long, M Virkkunen, M Linnoila, D Goldman, MU OPIOID RECEPTOR GENE VARIANTS : LACK OF ASSOCIATION WITH ALCOHOL DEPENDENCE Molecular Psychiatry. ,vol. 2, pp. 490- 494 ,(1997) , 10.1038/SJ.MP.4000331